miR-205 promotes tumor proliferation and invasion through targeting ESRRG in endometrial carcinoma

Oncology Reports

Volumn 29, Issue 6, 2013, Pages 2297-2302

  Su, Ning ^a   Qiu, Haifeng ^a   Chen, Yifei ^a   Yang, Tingting ^a   Yan, Qin ^a   Wan, Xiaoping ^a  

^a Shanghai Municipal Key Clinical Specialty   (China)

Author keywords

Endometrial endometrioid carcinoma; ESRRG; Invasion; miR 205; Proliferation

Indexed keywords

ESTROGEN RECEPTOR; ESTROGEN RELATED RECEPTOR GAMMA; MICRORNA 205; UNCLASSIFIED DRUG;

ARTICLE; CANCER STAGING; CARCINOGENESIS; CARCINOMA CELL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; ENDOMETRIUM CARCINOMA; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; BINDING SITES; CARCINOMA, ENDOMETRIOID; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; MICRORNAS; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; RECEPTORS, ESTROGEN; RNA INTERFERENCE; RNA, MESSENGER;

EID: 84876222702     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2400     Document Type: Article

References (19)

1. Siegel R, Ward E, Brawley O and Jemal A: Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61: 212-236, 2011.
2. De Souza Nunes LS, De Oliveira RV, Holgado LA, Nary Filho H, Ribeiro DA and Matsumoto MA: Use of bovine hydroxyapatite with or without biomembrane in sinus lift in rabbits: histopathologic analysis and immune expression of core binding factor 1 and vascular endothelium growth factor. J Oral Maxillofac Surg 69: 1064-1069, 2011.
3. Miska EA: How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 15: 563-568, 2005.
4. Esquela-Kerscher A and Slack FJ: Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269, 2006.
5. Chung TK, Cheung TH, Huen NY, Wong KW, Lo KW, Yim SF, Siu NS, Wong YM, Tsang PT, Pang MW, Yu MY, To KF, Mok SC, Wang VW, Li C, Cheung AY, Doran G, Birrer MJ, Smith DI and Wong YF: Dysregulated microRNAs and their predicted targets associated with endometrioid endometrial adenocarcinoma in Hong Kong women. Int J Cancer 124: 1358-1365, 2009.
6. Wu W, Lin Z, Zhuang Z and Liang X: Expression profile of mammalian microRNAs in endometrioid adenocarcinoma. Eur J Cancer Prev 18: 50-55, 2009.
7. Creasman W: Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet 105: 109, 2009.
8. Schmittgen TD and Livak KJ: Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108, 2008. (Pubitemid 351818697)
9. Lee JW, Choi CH, Choi JJ, Park YA, Kim SJ, Hwang SY, Kim WY, Kim TJ, Lee JH, Kim BG and Bae DS: Altered microRNA expression in cervical carcinomas. Clin Cancer Res 14: 2535-2542, 2008.
10. Jiang F, Liu T, He Y, Yan Q, Chen X, Wang H and Wan X: MiR-125b promotes proliferation and migration of type II endometrial carcinoma cells through targeting TP53INP1 tumor suppressor in vitro and in vivo. BMC Cancer 11: 425, 2011.
11. Yu J, Ryan DG, Getsios S, Oliveira-Fernandes M, Fatima A and Lavker RM: microRNA-184 antagonizes microRNA-205 to maintain SHIP2 levels in epithelia. Pro Natl Acad Sci USA 105: 19300-19305, 2008.
12. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP and Burge CB: Prediction of mammalian microRNA targets. Cell 115: 787-798, 2003. (Pubitemid 38058492)
13. Jiang J, Lee EJ, Gusev Y and Schmittgen TD: Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucleic Acids Res 33: 5394-5403, 2005. (Pubitemid 41548806)
14. Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, Bassi P, Sevignani C, Byrne D, Negrini M, Pagano F, Gomella LG, Croce CM and Baffa R: Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 25: 387-392, 2007. (Pubitemid 47362758)
15. Mouillet JF, Chu T, Nelson DM, Mishima T and Sadovsky Y: MiR-205 silences MED1 in hypoxic primary human trophoblasts. FASEB J 24: 2030-2039, 2010.
16. Gandellini P, Folini M, Longoni N, Pennati M, Binda M, Colecchia M, Salvioni R, Supino R, Moretti R, Limonta P, Valdagni R, Daidone MG and Zaffaroni N: miR-205 exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon. Cancer Res 69: 2287-2295, 2009.
17. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y and Goodall GJ: The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10: 593-601, 2008. (Pubitemid 351627379)
18. Tiraby C, Hazen BC, Gantner ML and Kralli A: Estrogen-related receptor gamma promotes mesenchymal-to-epithelial transition and suppresses breast tumor growth. Cancer Res 71: 2518-2528, 2011.
19. Yu S, Wang X, Ng CF, Chen S and Chan FL: ERRγ suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer. Cancer Res 67: 4904-4914, 2007. (Pubitemid 46915313)